NEWSROOM
July 26, 2010 Benchmark Achieved For Clinical Trial of Cytolin®.
June 17, 2010 CytoDyn Welcomes Banker Kenneth J. Van Ness to its Board of Directors.
March 31, 2010 CytoDyn Raises Three Million Dollars in Private Placements.
March 22, 2010 CytoDyn Increases Study Budget to Accelerate Clinical Trial.
March 17, 2010 CytoDyn Begins Full Humanization of Cytolin®.
January 19, 2010 Enrollment Open For Clinical Trial of Cytolin®, A Novel Immune Therapy From CytoDyn For Treating Early HIV Infection.
January 6, 2010 CytoDyn's New Approach to Drug Development: Why We Think It's Better.
October 8, 2009 CytoDyn Transfers Research on Unique AIDS Drug to Massachusetts General Hospital.
July 22, 2009 CytoDyn Completes Safety Testing of Cytolin®: Benchmark for Improved Treatment of HIV/AIDS.
July 7, 2009 CytoDyn Names New CFO, Welcomes New Cirector.
June 14, 2009 CytoDyn Explains How Documentary Movies Are Made.
May 11, 2009 Independent TV Producer Taping Documentary About CytoDyn.
March 9, 2009 CytoDyn Responds to FDA as High Court Rules Agency Cannot Guarantee Drug Safety.
February 13, 2009 CytoDyn Makes Site Visit to Inspect Product.
December 2, 2008 CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases.
October 21, 2008 CytoDyn Files New IND for Cytolin®.
October 7, 2008 CytoDyn Relocates Offices to Accommodate Expanded Activities.
July 2, 2008─CytoDyn Begins GMP Manufacturing of its
First-In-Class AIDS Drug.